Literature DB >> 8886821

The role of hyperglycemia in the development of diabetic complications.

E Schleicher1, A Nerlich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8886821     DOI： 10.1055/s-2007-979817

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN： 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  10 in total

1.  CCN-2 is up-regulated by and mediates effects of matrix bound advanced glycated end-products in human renal mesangial cells.

Authors:  Xiaoyu Wang; Susan V McLennan; Stephen M Twigg
Journal:  J Cell Commun Signal       Date:  2011-06-02       Impact factor: 5.782

Review 2.  Advanced glycation end products and diabetic retinopathy.

Authors:  Yashodhara Sharma; Sandeep Saxena; Arvind Mishra; Anita Saxena; Shankar Madhav Natu
Journal:  J Ocul Biol Dis Infor       Date:  2013-04-19

3.  Mastering a mediator: blockade of CCN-2 shows early promise in human diabetic kidney disease.

Authors:  Stephen M Twigg
Journal:  J Cell Commun Signal       Date:  2010-10-19       Impact factor: 5.782

4.  Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.

Authors:  Zhen-Ya Lu; Chao Cen; Zhou Shao; Xin-Hua Chen; Cheng-Fu Xu; You-Ming Li
Journal:  World J Gastroenterol       Date:  2016-02-07       Impact factor: 5.742

5.  Human munc13 is a diacylglycerol receptor that induces apoptosis and may contribute to renal cell injury in hyperglycemia.

Authors:  Y Song; M Ailenberg; M Silverman
Journal:  Mol Biol Cell       Date:  1999-05       Impact factor: 4.138

6.  High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells.

Authors:  V Kolm-Litty; U Sauer; A Nerlich; R Lehmann; E D Schleicher
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

7.  Six-Month Periodic Fasting in Patients With Type 2 Diabetes and Diabetic Nephropathy: A Proof-of-Concept Study.

Authors:  Alba Sulaj; Stefan Kopf; Ekaterina von Rauchhaupt; Elisabeth Kliemank; Maik Brune; Zoltan Kender; Hannelore Bartl; Fabiola Garcia Cortizo; Katarina Klepac; Zhe Han; Varun Kumar; Valter Longo; Aurelio Teleman; Jürgen G Okun; Jakob Morgenstern; Thomas Fleming; Julia Szendroedi; Stephan Herzig; Peter P Nawroth
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

8.  Reactive oxygen species, apoptosis and altered NGF-induced signaling in PC12 pheochromocytoma cells cultured in elevated glucose: an in vitro cellular model for diabetic neuropathy.

Authors:  E Lelkes; B R Unsworth; P I Lelkes
Journal:  Neurotox Res       Date:  2001-04       Impact factor: 3.911

9.  Exploring the Antihyperglycemic Chemical Composition and Mechanisms of Tea Using Molecular Docking.

Authors:  Yue Sun; Lufei Wang; Lily K Shaughnessy; Yan Lin; Qingliang Xu; Xueping Shi; Liang Zhang; Rilei Yu; Hang Xiao; Xiaochun Wan; Xian Wu
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-02       Impact factor: 2.629

10.  Single Nucleotide Polymorphism in the ADIPOQ Gene Modifies Adiponectin Levels and Glycemic Control in Type Two Diabetes Mellitus Patients.

Authors:  Mahmoud A Alfaqih; Aisha Al-Hawamdeh; Zouhair O Amarin; Yousef S Khader; Khawla Mhedat; Mohammed Z Allouh
Journal:  Biomed Res Int       Date:  2022-04-27       Impact factor: 3.246
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.